{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:06:20Z","timestamp":1790111180151,"version":"4.0.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-11631-z","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T01:03:27Z","timestamp":1746061407000},"page":"7064-7073","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Imaging features of wild-type transthyretin amyloid cardiomyopathy in gated and non-gated contrast-enhanced CT"],"prefix":"10.1007","volume":"35","author":[{"given":"Shinpei","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4101-5113","authenticated-orcid":false,"given":"Seitaro","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kidoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Kuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Oguni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Takashio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Usuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Izumiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Nagayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nakaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatoshi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"11631_CR1","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","volume":"126","author":"FL Ruberg","year":"2012","unstructured":"Ruberg FL, Berk JL (2012) Transthyretin (TTR) cardiac amyloidosis. Circulation 126:1286\u20131300","journal-title":"Circulation"},{"key":"11631_CR2","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1253\/circj.CJ-20-0110","volume":"84","author":"H Kitaoka","year":"2020","unstructured":"Kitaoka H, Izumi C, Izumiya Y et al (2020) JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis. Circ J 84:1610\u20131671","journal-title":"Circ J"},{"key":"11631_CR3","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1148\/rg.2020190069","volume":"40","author":"S Oda","year":"2020","unstructured":"Oda S, Kidoh M, Nagayama Y et al (2020) Trends in diagnostic imaging of cardiac amyloidosis: emerging knowledge and concepts. Radiographics 40:961\u2013981","journal-title":"Radiographics"},{"key":"11631_CR4","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B et al (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 379:1007\u20131016","journal-title":"N Engl J Med"},{"key":"11631_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams D, Gonzalez-Duarte A, O\u2019Riordan WD et al (2018) Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med 379:11\u201321","journal-title":"N Engl J Med"},{"key":"11631_CR6","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1253\/circj.CJ-22-0683","volume":"87","author":"Y Ichikawa","year":"2023","unstructured":"Ichikawa Y, Oota E, Odajima S et al (2023) Impact of tafamidis on echocardiographic cardiac function of patients with transthyretin cardiac amyloidosis. Circ J 87:508\u2013516","journal-title":"Circ J"},{"key":"11631_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa2409134","volume":"392","author":"M Fontana","year":"2024","unstructured":"Fontana M, Berk JL, Gillmore JD et al (2024) Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy. N Engl J Med 392:33\u201344. https:\/\/doi.org\/10.1056\/NEJMoa2409134","journal-title":"N Engl J Med"},{"key":"11631_CR8","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1007\/s00330-023-10129-w","volume":"34","author":"H Hayashi","year":"2024","unstructured":"Hayashi H, Oda S, Kidoh M et al (2024) Myocardial extracellular volume quantification in cardiac amyloidosis: a comparative study between cardiac computed tomography and magnetic resonance imaging. Eur Radiol 34:1016\u20131025","journal-title":"Eur Radiol"},{"key":"11631_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12968-017-0376-0","volume":"19","author":"LK Williams","year":"2017","unstructured":"Williams LK, Forero JF, Popovic ZB et al (2017) Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics. J Cardiovasc Magn Reson 19:61","journal-title":"J Cardiovasc Magn Reson"},{"key":"11631_CR10","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00330-019-06418-y","volume":"30","author":"T Emoto","year":"2020","unstructured":"Emoto T, Kidoh M, Oda S et al (2020) Myocardial extracellular volume quantification in cardiac CT: comparison of the effects of two different iterative reconstruction algorithms with MRI as a reference standard. Eur Radiol 30:691\u2013701","journal-title":"Eur Radiol"},{"key":"11631_CR11","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1253\/circj.CJ-23-0948","volume":"88","author":"H Yamasaki","year":"2024","unstructured":"Yamasaki H, Kondo H, Shiroo T et al (2024) Efficacy of computed tomography-based evaluation of myocardial extracellular volume combined with red flags for early screening of concealed cardiac amyloidosis in patients with atrial fibrillation. Circ J 88:1167\u20131175","journal-title":"Circ J"},{"key":"11631_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jcmg.2015.05.014","volume":"9","author":"J Ternacle","year":"2016","unstructured":"Ternacle J, Bodez D, Guellich A et al (2016) Causes and consequences of longitudinal LV dysfunction assessed by 2D strain echocardiography in cardiac amyloidosis. JACC Cardiovasc Imaging 9:126\u2013138","journal-title":"JACC Cardiovasc Imaging"},{"key":"11631_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.radcr.2018.09.025","volume":"14","author":"S Oda","year":"2019","unstructured":"Oda S, Kawano Y, Okuno Y et al (2019) Base-to-apex gradient pattern of cardiac impairment identified on myocardial T1 mapping in cardiac amyloidosis. Radiol Case Rep 14:72\u201374","journal-title":"Radiol Case Rep"},{"key":"11631_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jcmg.2017.06.020","volume":"11","author":"BW Sperry","year":"2018","unstructured":"Sperry BW, Vranian MN, Tower-Rader A et al (2018) Regional variation in technetium pyrophosphate uptake in transthyretin cardiac amyloidosis and impact on mortality. JACC Cardiovasc Imaging 11:234\u2013242","journal-title":"JACC Cardiovasc Imaging"},{"key":"11631_CR15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12968-016-0240-7","volume":"18","author":"R Li","year":"2016","unstructured":"Li R, Yang ZG, Wen LY et al (2016) Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance. J Cardiovasc Magn Reson 18:16","journal-title":"J Cardiovasc Magn Reson"},{"key":"11631_CR16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/ejhf.3137","volume":"26","author":"L Chacko","year":"2024","unstructured":"Chacko L, Kotecha T, Ioannou A et al (2024) Myocardial perfusion in cardiac amyloidosis. Eur J Heart Fail 26:598\u2013609","journal-title":"Eur J Heart Fail"},{"key":"11631_CR17","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00392-020-01693-y","volume":"110","author":"SG Saba","year":"2021","unstructured":"Saba SG, Gannon MP, Majure DT et al (2021) Cardiac amyloidosis CT sign. Clin Res Cardiol 110:1841\u20131846","journal-title":"Clin Res Cardiol"},{"key":"11631_CR18","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1007\/s00380-015-0658-0","volume":"31","author":"H Hashimura","year":"2016","unstructured":"Hashimura H, Ishibashi-Ueda H, Yonemoto Y et al (2016) Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia. Heart Vessels 31:990\u2013995","journal-title":"Heart Vessels"},{"key":"11631_CR19","doi-asserted-by":"publisher","unstructured":"Netti L, Ioannou A, Martinez-Naharro A et al (2024) Microvascular obstruction in cardiac amyloidosis. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.3481","DOI":"10.1002\/ejhf.3481"},{"key":"11631_CR20","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1136\/heartjnl-2015-308657","volume":"102","author":"A Senapati","year":"2016","unstructured":"Senapati A, Sperry BW, Grodin JL et al (2016) Prognostic implication of relative regional strain ratio in cardiac amyloidosis. Heart 102:748\u2013754","journal-title":"Heart"},{"key":"11631_CR21","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","volume":"12","author":"A Martinez-Naharro","year":"2019","unstructured":"Martinez-Naharro A, Kotecha T, Norrington K et al (2019) Native T1 and extracellular volume in transthyretin amyloidosis. JACC Cardiovasc Imaging 12:810\u2013819","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11631-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11631-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11631-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:02:16Z","timestamp":1761627736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11631-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":21,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["11631"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11631-z","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Prof. Toshinori Hirai, Kumamoto University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"We have no direct or indirect financial interest in the products used or the subject matter discussed in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Only if the study is on human subjects, written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Of the final study sample of wild-type ATTR-CM patients, 29 cases overlapped with the cohort from a previous study that compared ECV values between cardiac CT and CMR. In contrast to the prior study, this research focused on evaluating imaging findings obtained from conventional non-gated contrast-enhanced CT [\n                      \n                      ].","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}